Cryoport Launching Logistics Study for Bioanalytical and Clinical Trial Materials

August 30, 2016

Cryoport launched a study examining the effects of temperature and transport packaging on biomarkers and cell-therapy cancer vaccines. Currently, little research has examined shipping conditions’ effect on sample integrity. The study results will help educate clients and ensure that the most optimal shipping conditions are used when transporting materials for clinical trials. Mark W. Sawicki, Ph.D., chief commercial officer of Cryoport, explains the impact in an interview with Outsourcing Pharma. Read more >

Questions or comments? We welcome your feedback!

Email Us

Tags: Temperature Controlled Logistics, Cryoport News